Neoleukin Therapeutics Inc. (NLTX): What The Numbers Tell Us

The stock of Neoleukin Therapeutics Inc. (NASDAQ:NLTX) increased by $0.05 on Tuesday to finish at $0.67, up 8.17 percent. The last five days have seen an average of 533,760 shares of common stock traded. 19 times new highs were reached in the current year, with a gain of $0.1610. The average number of shares traded […]